Program Book
Program Book
Program Book
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
have highlighted a role for specific cell signaling pathways and the<br />
tumor microenvironment in the biology of this tumor. In this study we<br />
performed immunohistochemical studies in a relatively large series of<br />
OPG using tissue microarrays.<br />
Methods. Tumors from 59 patients with a median age of 9 years (range<br />
3 mo-66 years; 33 F,26 M) were tested using formalin-fixed paraffin<br />
embedded material in tissue microarrays. Immunohistochemistry<br />
was performed using antibodies recognizing mTOR pathway signaling<br />
components (total mTOR protein, Phospho-4E-BP1, PhosphoeIf4G,<br />
phosho-S6), microglia (CD68), markers of senescence (p16),<br />
and mutant IDH1 protein. Scoring was performed using a 4-tiered<br />
semiquantitative scale (0-4+). IDH1 was scored as positive or negative.<br />
Immunohistochemistry for GFAP was performed to evaluate for adequacy<br />
of immunoreactivity.<br />
Results. Immunohistochemical stains demonstrated frequent staining<br />
for mTOR pathway components, including moderate (2+) to strong (3+)<br />
staining for total mTOR (50%), phospho-4E-BP1 (42%), phospho-eIf4G<br />
(75%), and phospho-S6 (70%). Moderate to marked numbers of CD68<br />
positive microglia were identified in 44% of cases. Moderate to diffuse<br />
nuclear immunoreactivity for p16 was identified in 59% of cases. All<br />
cases (except for 1) were immunonegative for IDH1 mutant protein.<br />
Conclusions. OPG demonstrate increased total/activated levels of mTOR<br />
signaling components supporting an important role for this pathway<br />
in its biology. In addition, increased numbers of CD68+ microglia and<br />
markers of senescence (p16) were identified. These findings merit<br />
further study and correlation with additional molecular markers to<br />
evaluate their clinical and biological significance.<br />
Financial disclosure. None<br />
EYELID, CONJUNTIVA & ORBIT<br />
Abstract Posters<br />
86<br />
Other Intra-ocular Tumors Posters<br />
131 OTp101<br />
PHOTODYNAMIC THERAPY FOR ACQUIRED ASTRO-<br />
CYTOMA<br />
Cinzia Mazzini, Maria Carla Donati, Giulia Pieretti, Ugo Menchini (cinzia.<br />
mazzini@unifi.it)<br />
Department of Specialistic Surgery Sciences, Eye Clinic, University of<br />
Florence, Florence, Italy.<br />
Purpose. Retinal astrocytomas are glial tumours of the RNFL arising from<br />
retinal astrocytes, often associated with systemic disorders ( tuberous<br />
sclerosis or neurofibromatosis) but they can also be found on retinal<br />
examination as isolated tumour. We report the case of epipapillary<br />
retinal astrocytoma associated with serous retinal detachment treated<br />
with photodynamic therapy (PDT).<br />
Methods. A 32-years old man was referred for an elevated whitish<br />
epipapillary lesion associated with retinal detachment. He had a history<br />
of multicellular carcinoma and melanocytic nevus of the scapular region.<br />
Visual acuity was 20/20 in both eyes. Fluorescein angiography revealed<br />
a hyperfluorescence of the lesion; B-scan showed a solid epipapillary<br />
tumour with high reflectivity, posterior shadowing, and a contiguous<br />
serous retinal detachment. OCT showed a solid elevation of the retinal<br />
layers associated with raised neuro-epithelium at the edge of the lesion.<br />
The clinical picture was consistent with “acquired astrocytoma”.<br />
Four years later, the patient complained of a severe visual loss in left<br />
eye. BCVA was 20/50 and fundus examination, echography, fluorescein<br />
angiography and OCT showed an enlargement of the lesion and retinal<br />
detachment, with macular exudation. PDT with verteporfirin was performed.<br />
Results. Three months after treatment visual acuity remained stable;OCT<br />
and echography revealed a decrease of subretinal fluid. One year later<br />
BCVA was 20/30, and retinal detachment was disappeared.<br />
Conclusions. PDT with verteporfin can induce regression of aggressive<br />
retinal astrocytomas and may prevent their progression to total retinal<br />
detachment and enucleation. In selected severe cases, PDT may be<br />
considered a first-line treatment for acquired astrocytomas.<br />
Financial disclosure. None<br />
530 OTp102<br />
MANAGEMENT OF PERIPAPILLARY HEMANGIOMA IN<br />
PEDIATRIC VHL DISEASE<br />
Prithvi Mruthyunjaya, MD (mruth001@mc.duke.edu)<br />
Ocular Oncology and Vitreoretinal Surgery Services, Duke Eye Center,<br />
Durham, NC<br />
Purpose. To describe the management of a peripapillary retinal<br />
hemangioma in a pediatric patient with von-Hippel-Lindau disease and<br />
to describe the early development of epiretinal proliferations in this<br />
disease.<br />
Methods. Case report of a 2 yo male with a strong family history of VHL<br />
disease who presents with a new peripapillary hemangioma associated<br />
with a dome-shaped epimacular elevation.<br />
Results. Intraoperative photodynamic therapy was performed with<br />
verteporfin and intravitreal Avastin on 2 occasions with subsequent<br />
inactivation of the peripapillary hemangioma. The macular elevation<br />
was likely due to vitreous traction on the macular hyloid bursa with